OBJECTIVE: To investigate the predictive value of early serum levels of S100B and glial fibrillary acidic protein (GFAP) in traumatic brain injury. METHODS: Sixty patients admitted within 24 h of trauma were included. Neurological status on admission (Glasgow Coma Scale), initial cranial computed tomography (CCT) studies (Marshall Computed Tomographic Classification), and outcome after 6 months (Glasgow Outcome Scale) were evaluated. S100B and GFAP levels were determined on admission and 24 h after trauma. RESULTS: Blood levels of S100B and GFAP were elevated following head trauma and quantitatively reflected the severity of trauma. S100B levels after 24 h and on admission were of higher predictive value than CCT findings or clinical examination. GFAP, but not S100B levels rapidly declined after trauma. CONCLUSIONS: Blood levels of S100B and GFAP indicate the severity of brain damage and are correlated with neurological prognosis after trauma. Both methods can yield additional prognostic information if combined with clinical and CCT findings.
OBJECTIVE: To investigate the predictive value of early serum levels of S100B and glial fibrillary acidic protein (GFAP) in traumatic brain injury. METHODS: Sixty patients admitted within 24 h of trauma were included. Neurological status on admission (Glasgow Coma Scale), initial cranial computed tomography (CCT) studies (Marshall Computed Tomographic Classification), and outcome after 6 months (Glasgow Outcome Scale) were evaluated. S100B and GFAP levels were determined on admission and 24 h after trauma. RESULTS: Blood levels of S100B and GFAP were elevated following head trauma and quantitatively reflected the severity of trauma. S100B levels after 24 h and on admission were of higher predictive value than CCT findings or clinical examination. GFAP, but not S100B levels rapidly declined after trauma. CONCLUSIONS: Blood levels of S100B and GFAP indicate the severity of brain damage and are correlated with neurological prognosis after trauma. Both methods can yield additional prognostic information if combined with clinical and CCT findings.
Authors: Melania M Bembea; William Savage; John J Strouse; Jamie McElrath Schwartz; Ernest Graham; Carol B Thompson; Allen Everett Journal: Pediatr Crit Care Med Date: 2011-09 Impact factor: 3.624
Authors: Andrea Kleindienst; Christian Schmidt; Hans Parsch; Irene Emtmann; Yu Xu; Michael Buchfelder Journal: Cardiovasc Psychiatry Neurol Date: 2010-07-08
Authors: Stefania Mondello; Linda Papa; Andras Buki; M Ross Bullock; Endre Czeiter; Frank C Tortella; Kevin K Wang; Ronald L Hayes Journal: Crit Care Date: 2011-06-24 Impact factor: 9.097
Authors: Clive Ballard; Emma Jones; Nathan Gauge; Dag Aarsland; Odd Bjarte Nilsen; Brian K Saxby; David Lowery; Anne Corbett; Keith Wesnes; Eirini Katsaiti; James Arden; Derek Amoako; Derek Amaoko; Nicholas Prophet; Balaji Purushothaman; David Green Journal: PLoS One Date: 2012-06-15 Impact factor: 3.240
Authors: Ryan C Turner; Brandon Lucke-Wold; Noelle Lucke-Wold; Alisa S Elliott; Aric F Logsdon; Charles L Rosen; Jason D Huber Journal: Int J Mol Sci Date: 2013-01-17 Impact factor: 5.923